So, we know know Todos' path forward for the most
Post# of 30027
(Total Views: 545)
Posted On: 07/30/2020 11:37:46 AM
So, we know know Todos' path forward for the most part and how AMBS works into that.
We have Hempori as a stand alone that's generating revenue revenue with increasing online orders as well as LOI
"We have signed multiple LOIs regarding product partnerships with leading companies, and international distribution channels, as well as leading doctors for professional sports teams (NFL/NBA) who love the pain cream" - Gerald
We have everything that is happening with EMOR including MANF, ESS and Phenoguard.
(The 20 million on the books from EMOR)
The Avant now Theralink shares.
ELTO Pharma is interesting.
I'm curious if there's a path forward in any way with the S. 204 Right To Try Act that was signed on My 30, 2020.
It's an interesting avenue to look at.
Aloha
We have Hempori as a stand alone that's generating revenue revenue with increasing online orders as well as LOI
"We have signed multiple LOIs regarding product partnerships with leading companies, and international distribution channels, as well as leading doctors for professional sports teams (NFL/NBA) who love the pain cream" - Gerald
We have everything that is happening with EMOR including MANF, ESS and Phenoguard.
(The 20 million on the books from EMOR)
The Avant now Theralink shares.
ELTO Pharma is interesting.
I'm curious if there's a path forward in any way with the S. 204 Right To Try Act that was signed on My 30, 2020.
It's an interesting avenue to look at.
Aloha
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼